Status:
UNKNOWN
CT Scan Guide Percutaneous Biopsy of Lytic Bone Metastases of Lung Cancer : Contribution in Pathology Diagnosis and Molecular Biology
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Image-Guided Biopsy - Carcinoma, Bronchogenic / Diagnosis- Outpatients
Eligibility:
All Genders
Brief Summary
In case of primary lung cancer, bone metastases biopsy can be done in initial diagnosis or follow-up. Nevertheless, any study focus on rentability and biopsy complications of lytic bone lesion for th...
Detailed Description
Current progress in thoracic oncology require to be able to carry out analysis by molecular biology. So biopsies are done several times during cancer progression. But risk is high for a lung biopsy wi...
Eligibility Criteria
Inclusion
- CT scan guide percutaneous biopsy of lytic bone metastases
- register on CHU Grenoble Alpes radiology software between January 2010 and June 2017
- Patient who have a clinical context of lung cancer with bone metastases
Exclusion
- Person deprived of liberty by judicial order
- Opposition expressed by patient
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03386916
Start Date
January 1 2010
End Date
September 1 2018
Last Update
December 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.